Jump Financial, LLC Novartis Ag Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 21, 2024	SELL	$94.73 - $105.13 $113,012 - $125,420	-1,193 Reduced 32.38%	2,491 $253,000
Q3 2023 Nov 07, 2023	SELL	$94.73 - $105.13 $113,012 - $125,420	-1,193 Reduced 32.38%	2,491 $253,000
Q2 2023 Oct 21, 2024	BUY	$92.52 - $104.91 $340,843 - $386,488	3,684 New	3,684 $371,000
Q2 2023 Aug 07, 2023	BUY	$92.52 - $104.91 $340,843 - $386,488	3,684 New	3,684 $371,000
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $187,061 - $229,079	2,476 New	2,476 $224,000
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $531,060 - $626,269	-6,360 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $24,435 - $29,556	-313 Reduced 4.69%	6,360 $601,000
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $548,120 - $607,243	6,673 New	6,673 $581,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.